Kenneth Truitt's most recent trade in Aquestive Therapeutics Inc was a trade of 100,000 Non-Qualified Stock Option (right to buy) done . Disclosure was reported to the exchange on Sept. 6, 2022.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics Inc | Kenneth Truitt | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Sep 2022 | 100,000 | 100,000 | - | - | Non-Qualified Stock Option (right to buy) |